We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Premaitha | LSE:NIPT | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 9.10 | 9.00 | 9.20 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMNIPT
RNS Number : 8716E
Premaitha Health PLC
14 February 2018
TR-1: Standard form for notification of major holdings
Hot Features
Premium
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer and to the FCA in Microsoft Word format if possible)(i)
-----------------------------------------------------------------------------------------------------------
1a. Identity of the issuer Premaitha Health plc
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
-------------------------------------------------- -------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
-----------------------------------------------------------------------------------------------------------
Non-UK issuer
---------------------------------------------------------------------------------------- -----------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
-----------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
---------------------------------------------------------------------------------------- -----------------
An acquisition or disposal of financial instruments X
---------------------------------------------------------------------------------------- -----------------
An event changing the breakdown of voting rights
---------------------------------------------------------------------------------------- -----------------
Other (please specify)(iii) :
---------------------------------------------------------------------------------------- -----------------
3. Details of person subject to the notification obligation(iv)
Name Life Technologies Limited,
a company incorporated in
Scotland with company number
SC083107
City and country of registered
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
-----------------------------------------------------------------------------------------------------------
Name
-------------------------------------------------- -------------------------------------------------------
City and country of registered
office (if applicable)
-------------------------------------------------- -------------------------------------------------------
5. Date on which the threshold 9 February 2018
was crossed or reached(vi)
:
-------------------------------------------------- -------------------------------------------------------
6. Date on which issuer notified 13 February 2018
(DD/MM/YYYY):
-------------------------------------------------- -------------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
-----------------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
--------------------- ------------------------- ------------------ ---------------- -------------------
Resulting 29.79% (based 321,218,279
situation on current (based on
on the date share capital) current
on which and 22.95% share capital)
threshold (based on and 416,906,985
was crossed so-enlarged (based on
or reached share capital) so-enlarged
share capital)
--------------------- ------------------------- ------------------ ---------------- -------------------
Position 25.92% (based
of previous on current
notification share capital)
(if and 19.97%
applicable) (based on
so-enlarged
share capital)
--------------------- ------------------------- ------------------ ---------------- -------------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
---------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
------------------- ------------------------- ------------------ ------------------------------ ----------------
SUBTOTAL
8. A
--------------------- --------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
--------------------- ----------------------- ------------------ -------------------------------- ----------------
SUBTOTAL 8.
B 1
------------------ -------------------------------- ----------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable Physical 20,325,204 6.33% (based
2023 up to 11 on current
December share capital)
2023 and 4.88%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable Physical 17,094,018 5.32% (based
2023 up to 11 on current
December share capital)
2023 and 4.10%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable Physical 16,913,319 5.27% (based
2023 up to 11 on current
December share capital)
2023 and 4.06%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable Physical 28,938,797 9.01% (based
2023 up to 11 on current
December share capital)
2023 and 6.94%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable Physical 12,417,368 3.87% (based
2023 up to 11 on current
December share capital)
2023 and 2.98%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
SUBTOTAL 95,688,706 29.79% (based
8.B.2 on current
share capital)
and 22.95%
(based on
so-enlarged
share capital)
--------------------- ----------- ----------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which X
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
--------------------------------------------------------------- ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
------------------ ---------------- ----------------------- -----------------------
Thermo Fisher 29.79% (based
Scientific Inc. on current share
capital) and
22.95% (based
on so-enlarged
share capital)
------------------ ---------------- ----------------------- -----------------------
Thermo Fisher 29.79% (based
Scientific Life on current share
Holdings Limited capital) and
22.95% (based
on so-enlarged
share capital)
------------------ ---------------- ----------------------- -----------------------
Life Technologies 29.79% (based
Limited on current share
capital) and
22.95% (based
on so-enlarged
share capital)
------------------ ---------------- ----------------------- -----------------------
10. In case of proxy voting, please identify:
--------------------------------------------------------------------------------------
Name of the proxy holder
------------------------------------ ------------------------------------------------
The number and % of voting
rights held
------------------------------------ ------------------------------------------------
The date until which the
voting rights will be held
------------------------------------ ------------------------------------------------
11. Additional information(xvi)
--------------------------------------------------------------------------------------
Place of completion London, United Kingdom
-------------------- -----------------------
Date of completion 13 February 2018
-------------------- -----------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSURRWUAUAAR
(END) Dow Jones Newswires
February 14, 2018 05:25 ET (10:25 GMT)
1 Year Premaitha Chart |
1 Month Premaitha Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
